Cite
A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer’s disease
MLA
Suki Greaves, et al. A Population Approach to Characterise Amisulpride Pharmacokinetics in Older People and Alzheimer’s Disease. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10bbd0112057eb620d04a48e5dc35850&authtype=sso&custid=ns315887.
APA
Suki Greaves, Alan Smith, Julie Bertrand, Emma McLachlan, David Taylor, Suzanne Reeves, Fabrizia D’Antonio, Akshay Nair, Stuart Brownings, & Robert Howard. (2016). A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer’s disease.
Chicago
Suki Greaves, Alan Smith, Julie Bertrand, Emma McLachlan, David Taylor, Suzanne Reeves, Fabrizia D’Antonio, Akshay Nair, Stuart Brownings, and Robert Howard. 2016. “A Population Approach to Characterise Amisulpride Pharmacokinetics in Older People and Alzheimer’s Disease,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10bbd0112057eb620d04a48e5dc35850&authtype=sso&custid=ns315887.